California Drug Coupon Ban Bill Draws Mixed Views, Impact Uncertain

February 24, 2017 at 5:28 PM
A new bill introduced in the California state legislature would ban drug companies from offering consumers coupons for drugs that have a lower cost alternative, prompting concerns from the Pharmaceutical Research and Manufacturers of America and the California Life Sciences Association (CLSA). The author of the bill told Inside Health Policy that he hopes the measure will highlight what he sees as the inappropriate pricing practices and bring drug makers to the table. One other state, Massachusetts, previously banned...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.